Atlantis, FLNCT07589595Now EnrollingIRB Ready

Cognitive Dysfunction Clinical Trial in Atlantis, FL

Access cutting-edge cognitive dysfunction treatment through this clinical trial at a research site in Atlantis. Study-provided care at no cost to qualified participants.

Sponsored by Eli Lilly and Company

Quick Self-Assessment

See if you qualify for this Atlantis location

Preparing your pre-screening questions…

Expert Care in Atlantis

Access cognitive dysfunction specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cognitive dysfunction treatment provided free

Apply for This Atlantis Location

Check if you qualify for this cognitive dysfunction clinical trial in Atlantis, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Atlantis

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Atlantis site if eligible
  4. 4Begin participation

About This Cognitive Dysfunction Study in Atlantis

The main purpose of this study is to evaluate whether treatment with donanemab slows the progression of cognitive (how we think, learn, remember, pay attention, and make decisions) and functional (how we are able to perform daily activities) decline. For each participant, the study will last one and a half years.

Sponsor: Eli Lilly and Company

Who Can Participate

Inclusion Criteria

Have gradual and progressive cognitive decline for greater than or equal to ( ≥) 6 months.
Have least 1 core clinical feature of dementia with Lewy bodies (DLB).
Have a score ≥20 on Montreal Cognitive Assessment (MoCA).
Meet plasma P-tau217 criteria.
Have a cerebrospinal fluid (CSF) result consistent with the presence of brain amyloid pathology.
Have a CSF result consistent with the presence of alpha-synuclein pathology.
Have at least 1 reliable study partner who will provide written informed consent to participate, is in frequent contact with the participant, and is familiar with overall function and behavior, such as day-to-day activities and cognitive abilities.

Exclusion Criteria

Have a disease or condition that could interfere with this study or is a current serious or unstable illness.
Have, or is suspected to have, a significant neurological disease (other than the studied condition) that affects the central nervous system and may affect the individual's cognition or ability to complete the study.
Have a history of cancer that, in the investigator's opinion, has a high risk of recurrence and preventing the completion of the study.
Have clinically significant multiple or severe drug allergies, significant atopy, or severe posttreatment hypersensitivity reactions.
Have previously received amyloid-targeting therapy.
Active immunization against amyloid-beta.
Have a centrally read MRI that does not meet study entry criteria.
Have contraindication to MRI or PET scans.
Have any contraindication to lumbar puncture.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Atlantis?

Yes, this clinical trial (NCT07589595) has an active research site in Atlantis, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cognitive Dysfunction Treatment Options in Atlantis, FL

If you're searching for cognitive dysfunction treatment options in Atlantis, FL, this clinical trial (NCT07589595) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Atlantis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cognitive dysfunction specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in Atlantis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Atlantis, FL